Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-4-12
pubmed:abstractText
Previous studies have shown that non-erosive reflux disease (NERD) patients are less sensitive to proton pump inhibitor (PPI) treatment than patients with erosive reflux disease. The aim of this study was to investigate whether treatment with prokinetics in addition to omeprazole therapy would improve clinical symptoms, gastric emptying and esophageal peristalsis in PPI-resistant NERD patients with or without delayed gastric emptying.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1435-5922
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
413-21
pubmed:meshHeading
pubmed-meshheading:19997942-Adult, pubmed-meshheading:19997942-Anti-Ulcer Agents, pubmed-meshheading:19997942-Benzamides, pubmed-meshheading:19997942-Case-Control Studies, pubmed-meshheading:19997942-Double-Blind Method, pubmed-meshheading:19997942-Drug Resistance, pubmed-meshheading:19997942-Drug Therapy, Combination, pubmed-meshheading:19997942-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:19997942-Female, pubmed-meshheading:19997942-Gastric Emptying, pubmed-meshheading:19997942-Gastroesophageal Reflux, pubmed-meshheading:19997942-Gastrointestinal Agents, pubmed-meshheading:19997942-Ghrelin, pubmed-meshheading:19997942-Humans, pubmed-meshheading:19997942-Male, pubmed-meshheading:19997942-Manometry, pubmed-meshheading:19997942-Middle Aged, pubmed-meshheading:19997942-Morpholines, pubmed-meshheading:19997942-Omeprazole, pubmed-meshheading:19997942-Proton Pump Inhibitors
pubmed:year
2010
pubmed:articleTitle
The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.
pubmed:affiliation
Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan. seiji.futagami@gmail.com
pubmed:publicationType
Journal Article, Controlled Clinical Trial, Research Support, Non-U.S. Gov't